Squarepoint
LABU icon

Squarepoint’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Squarepoint’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,800
Closed -$287K – 4644
2025
Q4 		$287K Buy
+1,800
New +$247K ﹤0.01% 3629
2025
Q1 		– Sell
-13,700
Closed -$1.23M – 5044
2024
Q4 		$1.23M Buy
+13,700
New +$1.61M ﹤0.01% 2861

Other funds holding LABU

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $885M AUM 47.78% 1-Year Est. Return
Belvedere Trading
Belvedere Trading Chicago, Illinois $84.4B AUM 52.68% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Squarepoint's LABU Position: Q4 2025 in Review

Squarepoint sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q4 2025, closing a stake of 73,394 shares — an estimated $10.1M sold.

Squarepoint first reported a position in LABU in Q4 2021 and held it in 13 quarters. The position peaked at $9.17M in Q2 2025. 40 funds tracked by Wall St. Rank hold LABU as of Q4 2025.

  • Squarepoint reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q4 2025 after selling out during the quarter.
  • Squarepoint sold 73,394 Direxion Daily S&P Biotech Bull 3X ETF shares in Q4 2025, an estimated $10.1M.
  • Squarepoint first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2021 and held it in 13 quarters.
  • Squarepoint's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $9.17M in Q2 2025.
  • 40 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q4 2025.

Based on Squarepoint's 13F filing for Q4 2025, filed 13 Feb 2026.